Strong fundamental, increasing profit margin (2016-2019), considerably low PE among pharmaceutical counters.
A clear up trend since 2009 and currently within a bullish channel from May'20 UTD, coupled with good signal from OBV, therefore a plausible TP of 4.0.
A clear up trend since 2009 and currently within a bullish channel from May'20 UTD, coupled with good signal from OBV, therefore a plausible TP of 4.0.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.